Posts Tagged ‘University of Florida’
Wednesday, March 2nd, 2011
 University of Florida computer researcher Herman Lam (left) and Alan George, founder and director of the NSF CHREC Center, display UF’s supercomputer, the Novo-G, on Feb. 8, 2011. The Novo-G, built and developed at UF, is believed to be the world’s most powerful reconfigurable computer.
GAINESVILLE, Fla. — University of Florida researchers say their supercomputer, named Novo-G, is the world’s fastest reconfigurable supercomputer and is able to perform some important science applications faster than the Chinese supercomputer touted as the world’s most powerful.
In November, the TOP500 list of the world’s most powerful supercomputers, for the first time ever, named the Chinese Tianhe-1A system at the National Computer Center in Tainjin, China as No. 1.
In his state of the union speech, President Barack Obama noted, “Just recently, China became home of the world’s largest solar research facility, and the world’s fastest computer.”
But that list does not include reconfigurable supercomputers such as Novo-G, built and developed at the University of Florida, said Alan George, UF professor and director of the National Science Foundation’s Center for High-Performance Reconfigurable Computing, known as CHREC.
Novo-G most powerful reconfigurable machine
“Novo-G is believed to be the most powerful reconfigurable machine on the planet and, for some applications, it is the most powerful computer of any kind on the planet,” George said.
“It is very difficult to accurately rank supercomputers because it depends upon what you want them to do,” George said, adding that the TOP500 list ranks supercomputers by their performance on a few basic routines in linear algebra using 64-bit, floating-point arithmetic.
However, a significant number of the most important applications in the world do not adhere to that standard, including a growing list of vital applications in health and life sciences, signal and image processing, financial science, and more under study with Novo-G at Florida.
New, innovative form of computing
Most of the world’s computers, from smart-phones to laptops to Tianhe-1A, feature microprocessors with fixed-logic hardware structures. All software applications for these systems must conform to these fixed structures, which can lead to a significant loss in speed and increase in energy consumption.
By contrast, with reconfigurable machines, a relatively new and highly innovative form of computing, the architecture can adapt to match the unique needs of each application, which can lead to much faster speed and less wasted energy due to adaptive hardware customization.
Novo-G uses 192 reconfigurable processors and “can rival the speed of the world’s largest supercomputers at a tiny fraction of their cost, size, power, and cooling,” the researchers noted in a new article on Novo-G published in the January-February edition of the IEEE Computing in Science and Engineering magazine.
Conventional supercomputers, some the size of a large building, can consume up to millions of watts of electrical power, generating massive amounts of heat, whereas Novo-G is about the size of two home refrigerators and consumes less than 8,000 watts.
Later this year, researchers will double the reconfigurable capacity of Novo-G, an upgrade only requiring a modest increase in size, power, and cooling, unlike upgrades with conventional supercomputers.
Tags: Alan George, FL, Gainesville, Novo-G, reconfigurable computer, University of Florida Posted in Hardware, IT, University Tech | Comments Off
Wednesday, November 24th, 2010
ATLANTA – Southeast BIO (SEBIO) announced the winners of the Fourth Annual SEBIO Awards in a ceremony held at its Twelfth Annual Investor Forum in Atlanta, Georgia.
The awards honored companies in the following categories: Southeast (SE) Deal of the Year: Initial Funding; SE Deal of the Year: Venture Capital Transaction, and SE Deal of the Year: Strategic Transaction. In addition, the organization awarded its SE Leadership Award to an individual or organization that made a notable contribution to the growth of the life sciences industry in the region over the last year. The winners were InVasc Therapeutics Inc., TearScience Inc., Alimera Sciences Inc., and David Day of the University of Florida, respectively.
“Our SEBIO Annual Awards recognize those companies and individuals that are driving the growth of the Southeast region’s life sciences industry,” said former SEBIO Chair Garheng Kong, a General Partner with Sofinnova Ventures. “These success stories show the maturation of the industry in the Southeast and reflect very well on what is happening to those who have an interest in getting to know the region better. The SE Leadership Award, in particular, is a great way to highlight the role of individuals who really distinguish themselves by their unique contribution to our industry.”
InVasc Therapeutics, Inc. won the SE Deal of the Year: Initial Funding Award. InVasc was honored for its $3.15 million financing in July. The financing was led by Trois Investments Industriels Internationaux S.A., headquartered in Luxembourg. InVasc is a clinical stage biopharmaceutical company developing drugs to treat or prevent cardiometabolic disease. The company is currently focused on advancing two lead drugs for chronic kidney disease and atherosclerosis.
TearScience, Inc. won the SE Deal of the Year: Venture Capital Transaction Award. TearScience was honored for its $44.5 million Series C financing in May. New investors participating were Essex Woodlands Health Ventures, Investor Growth Capital, and General Catalyst. The company’s existing investors, De Novo Ventures, Spray Ventures, and Quaker BioVentures, completed the round. TearScience has pioneered diagnostic and treatment devices for evaporative dry eye, providing significant clinical improvement. Of the more than 100 million dry eye sufferers worldwide, approximately 70 percent have evaporative dry eye caused by lipid deficiency of the eye’s natural tear film. TearScience’s integrated, in-office system is the first to enable eye care professionals to address the root cause of evaporative dry eye.
Alimera Sciences, Inc. won the SE Deal of the Year: Strategic Transaction Award for its initial public offering and venture debt raise totaling more than $100 million earlier this year. On April 21, 2010, Alimera (Nasdaq: ALIM) completed its initial public offering of 6.55 million shares of common stock, resulting in net proceeds to Alimera of approximately $68.4 million. In October, 2010, Alimera obtained a $32.5 million senior secured credit facility to help fund its working capital requirements. Alimera is a publically traded biopharmaceutical company that specializes in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. Currently, Alimera’s main focus is on Iluvien, which is being developed for the treatment of diabetic macular edema.
David Day, director of the Office of Technology Licensing and Sid Martin Biotechnology Incubator at the University of Florida, was honored for the SE Leadership Award. David was recognized for his substantial involvement in SEBIO and his leadership in the growth of the life sciences industry in the Southeast. David has played a critical role in strengthening the life sciences industry in Florida and proactively working to attract capital to the region’s emerging companies.
He has served numerous roles within SEBIO, including Chair of the Investor Forum (2008), Chair of SEBIO (2010), and currently, Chair of the Standing SEBIO Investor Forum Committee.“These award winners have achieved outstanding success in 2010 and it’s a pleasure to honor them,” said SEBIO 2010 Awards Committee member Aaron Davidson, Managing Director with H.I.G. BioVentures. “We have high hopes for them in the future and believe that these recipients are an example of the many strong companies we have in the Southeast.”
Tags: Alimera Sciences, David Day, InVasc Therapeutics, SEBIO, TearScience Inc., University of Florida Posted in Biotech, Events, Florida, Georgia | Comments Off
Thursday, June 17th, 2010
WASHINGTON, DC – The U.S. Supreme Court is expected to hand down a decision affecting the Sarbanes-Oxley (SOX) act of 2002 soon. The Sarbanes-Oxley Act more than quadrupled corporate auditing costs for public corporations. Passed in response to the slack auditing that allowed companies such as Enron to appear healthy when they were not, SOX proved so costly that some public companies went private again, while it also reduced the number of companies going public.
That effect is still being felt in the venture financing industry, where a successful IPO is a coveted exit. We’ve heard from a number of smaller venture-backed firms that the cost of going public now means they aimed at a merger or acquisition exit from the start rather than for an IPO.
The case before the Supreme Court, says the Competitive Enterprise Institute (CEI) whose attorneys are service as co-counsel, mounts a constitutional challenge to the Public Company Accounting Oversight Board (PCAOB), the accounting regulatory body created by the law.
Negative impact on entrepreneurs
The CEI argues that the way in which the PCAOB board members are appointed violates the Appointments Clause of the U.S. Constitution. Namely, that PCAOB officers, who wield a great deal of regulatory power over businesses and industry-wide accounting practices, are “principal officers of the United States” who must be appointed by the President, with advice and consent of the Senate or by an agency head, as required by the Appointments Clause.
CEI says, “This requirement was intended by the Framers to instill a high level of accountability for officials who wield such vast powers. Although the PCAOB is a striking constitutional anomaly – a case of an independent agency (Securities and Exchange Commission) appointing an equally powerful independent agency – it’s a case that will also potentially change, for the better, how other government officials and regulatory bodies are answerable to the American people.”
CEI notes that SOX has had a negative impact on entrepreneurs and inventors.
Fewer IPOS
CEI says SOX permanently reduced the number of companies going public, increased the size of companies going public, and had a negative effect on job creation and economic growth. It also caused many foreign firms to stop listing on U.S. exchanges.
According to a 2009 Renaissance Capital report, IPO issuance in 2008 and 2009 is lower than any period since the 1970s, when business creation struggled against inflation, high interest rates and the Vietnam War.
Also, data compiled by Jay Ritter of the University of Florida show the number of U.S. IPOs were lower in every year after SOX was enacted in 2002 (2003 to present) than in every year of the decade from 1991 to 2000, including the early ’90s recession years. For instance, in the post-SOX boom year of 2006, there were 162 U.S. IPOs. Yet in 1991, a year when the U.S. was mired in recession but did not have SOX, there were 295 U.S. IPOs.
Bigger IPOs
The sheer size of companies going public has also increased, in large part because a company needs to be pretty big to afford the accounting costs that have shot up fourfold as a result of SOX, according to a summary of research in the Sarbanes-Oxley Compliance Journal.
According to Business Week, the median market cap (as measured by number of shares times share price) for a company doing an IPO was $52 million in the mid-‘90s. Today, it has shot up $227 million. Google had a $1 billion market cap when it went public of 2004. And Facebook still hasn’t gone public, despite having an estimated market cap of nearly $10 billion.
That means, says CEI, that budding Microsofts can no longer go public to raise money for growth. They must wait until they’re as big as a Google to go public. That forces firms to seek financing through debt, which is especially difficult in the current credit crunch.
CEI notes that evidence suggests that we were able to recover more quickly from the early ‘90s recession because an actual increase in companies — from Starbucks to Cisco — issuing IPOs. But SOX forecloses that possibility and makes for a longer recovery.
Accountants full employment act?
CEI also maintains that the PCAOB has stretched Sarbox’s requirement that auditors “attest” to a company’s internal controls over financial reporting in the law’s Section 404 to require a full-blown audit of trivial items that could remotely effect a financial statement. “This has turned the law into the “Accountants Full Employment Act” and the reason the Big 4 accounting firms lobby so hard against even minor rollbacks in Congress,” says CEI’s John Berlan, director of its Center for Entrepreneurs and Investors in a memo.
SOX was Hell for a company like Google
Even companies large enough to mount and IPO such as Google, faced difficulties with SOX.
According to John Battelle’s book The Search, considered a definitive history of Google Inc., Sarbox was “hell for a company like Google, which made its money literally pennies at a time, from millions upon millions of micro-transactions.”
Battelle reports that Sarbox compliance significantly delayed Google’s IPO. “According to engineers involved in the work, Google had to significantly restructure its advertising report system from the ground up.” If this was difficult for a company like Google, imagine what a burden it is to smaller companies.
SOX ineffective in fighting fraud
University of Minnesota accounting professor Ivy Zhang found that the law has cost the American economy $1.4 trillion in direct and indirect costs.
Almost as important is that Zhang and other researches have found that Sarbox has had no quantifiable benefits in fighting fraud. The PCAOB has done little or nothing about in telling accountants how to handle accounting for the off-balance sheet entities at issue in Enron that resurfaced with Lehman and other companies. Countrywide Financial, now charged by the SEC with accounting fraud, actually won an award for its Sarbox compliance from the Institute of Internal Auditors in 2007.
There is bipartisan support in Congress for regulatory relief from SOX.
For more see also:
Peter Thiel, venture capitalist and first outside investor in Facebook, “The IPO window is almost closed and I think in part, this is a response to Sarbanes-Oxley to the ways in which being the CEO of a public company is simply no fun anymore. They’re subject to insane levels of scrutiny. You’re not able to pursue any sort of multi-year corporate strategy and instead you are held to a quarter-by-quarter earnings schedule which is ultimately quite detrimental to long-term planning.” bigthink.com/ideas/17716
Carl Schramm and Robert Litan, president and vice president of Kauffman Foundation, leading foundation on research in entrepreneurship: “Compliance with the Sarbanes-Oxley Act of 2002, in particular, has proven to be far more expensive for smaller companies than originally intended or forecasted. Since shareholders are the intended beneficiaries of Sarbox, why not let them vote on whether their company needs to comply with some or all of its provisions—the expensive requirement for auditing of internal controls, in particular.
We suspect that many shareholders would choose some form of opt-out, and in so doing, would enable more growing companies to continue growing as independent firms, rather than being bought out by larger companies that can intentionally or unintentionally rob the firms of the entrepreneurial magic that made them successful in the first place.” online.wsj.com/article/SB10001424052748704013004574517303668357682.html
Commentary on the Daily Caller: Sarbox reform would boost our economy, but even small reforms (such as small company exemptions) are being blocked by the powerful accounting lobby: dailycaller.com/2010/02/02/obama-can-aid-small-businesses-by-providing-regulatory-relief/
CEI study, “SOXing It To The Little Guy,” detailing Sarbox’s cost to Main Street entrepreneurs and investors.
Jack Welch, General Electric CEO responsible for turnaround in 80s and 90s. ”Small companies with all these financial controls that are in there now and the penalties that go on with small entrepreneurial companies, it’s tough.” Interview with Tavis Smiley.www.pbs.org/kcet/tavissmiley/archive/200504/20050426_welch.html
Tags: Carl Schramm, CEI, Countrywide Financial, facebook, General Electric, Google, Ivy Zhang, Jack Welch, John Battelle, Kauffman Foundation, Peter Thiel, Robert Litan, SOX, Supreme Court ruling on Sarbanes-Oxley Act, University of Florida Posted in Alabama, Arkansas, Carolinas, Economic Development, Florida, Georgia, Government/Defense, Kentucky, Maryland, North Carolina, Other SE, Potomac, South Carolina, Tennessee, Virginia, Washington, DC, West Virginia | Comments Off
Monday, February 1st, 2010
 Artist's rendering of UF Innovation Hub.
GAINESVILLE, FL – The University of Florida has nabbed $8.2 million from the federal Economic Development Administration to being construction of its Florida Innovation Hub. The new facility is aimed at helping create more startups to commercialize UF research.
The grant is one of the largest ever made by the EDA’s Atlanta office.
The 45,000 square foot Hub will host UF’s Office of Technology Licensing and UF Tech Connect, the university’s commercialization offices.
It will also will provide technology start-up companies connected with the university with office space, laboratories, conference rooms and other capabilities.
“The hub will serve as a catalyst to get innovation from university laboratories into the marketplace, where it can have an impact on the world while creating jobs in Florida,” said UF President Bernie Machen, who noted that the university is contributing an additional $5 million in support.
The Hub is set to open in 2011.
UF currently averages about 10 new technology-based spin-outs a year.
Tags: incubator, Innovation Hub grant, Tech Transfer, University of Florida Posted in Economic Development, Florida, University Tech | Comments Off
|
|
|